]]>(MedPage Today) -- SAN FRANCISCO -- Radiotherapy beyond current standards failed to improve local control or survival for patients with locally advanced inoperable esophageal cancer, the phase III ARTDECO study indicated.
Among 260 patients...
Related topics: Cancer, Oncology, Medical Research
Research is beginning at Virginia Mason Medical Center that will evaluate the accuracy of a breath test for detecting esophageal cancer, one of the fastest growing and deadliest cancers in the United States.
Related topics: Cancer, Oncology, Medical Research
A simple health questionnaire could be a highly effective tool to pre-screen people for early signs of esophageal cancer, enabling much earlier diagnosis and treatment, finds a new study.
Related topics: Cancer, Oncology, Medical Research
]]>(MedPage Today) -- A deep-learning computer-aided detection (CAD) system identified neoplasia with high accuracy and near-perfect delineation performance in Barrett's esophagus (BE), achieving greater accuracy in primary detection than...
Related topics: Cancer, Oncology
Among people with psoriasis, the risk of skin, esophageal, liver and pancreatic cancer was particularly high.
Related topics: Psoriasis, Cancer, Liver Cancer, Pancreatic Cancer, Skin Cancer, Oncology
(MedPage Today) -- ATTRACTION-3: modest survival improvement in mostly Asian population still 'game-changing'
Related topics: Cancer, Oncology
The "Take Me Home Tonight" singer said his fate is in "God's hands."
Related topics: Cancer, Oncology
Esophageal cancer has now joined the list of tumor types that can be treated with a checkpoint inhibitor — in this case, with pembrolizumab (Keytruda). FDA Approvals
Related topics: Cancer, Oncology, Food And Drug Administration
It is difficult for physicians to estimate recurrence and survival in patients with esophageal cancer. Researchers have found that the response of lymph nodes, as opposed to that of primary tumors, to neoadjuvant chemotherapy is more effective in...
Related topics: Lymph Nodes, Cancer, Oncology, Medical Research, Chemotherapy
Researchers have identified, for the first time in esophageal cancer, the cancer killing capability of a lesser-known type of immune cell, presenting a new potential therapeutic target.
Related topics: Cancer, Oncology, Medical Research
Dr. Flores is a world-renowned thoracic surgeon known for his technical skill and life-long work on lung and esophageal cancer, mesothelioma and asbestos-related diseases.
Related topics: Lung Cancer, Cancer, Oncology
Tea drinkers who enjoy their beverages 140 degrees could increase their risk of esophageal cancer. Here's what to know about your favorite drinks.
Related topics: Medical Research, Cancer, Oncology
Research dating back to at least 2009 has indicated that drinking hot beverages may increase the risk for developing esophageal cancer, though it has been unclear if this risk can be directly correlated with the temperature that something is...
Related topics: Cancer, Oncology, Medical Research
(MedPage Today) -- DNA-damaging immune response in tumors correlates with neoadjuvant therapy efficacy, will aid personalized treatment
Related topics: Genetics, Cancer, Oncology, DNA
Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in the United States, according to new research.
Related topics: Cancer, Oncology, Medical Research
A benign esophageal stricture is a gradual narrowing of the esophagus that has no medical links to cancer. Learn more about the condition here.
Related topics: Cancer, Oncology
The Warbeast and Rigor Mortis vocalist was diagnosed with esophageal cancer in 2017, and entered hospice care earlier this month.
Continue reading…
Related topics: Cancer, Oncology
New research could result in a simple and inexpensive screening for cancer of the esophagus -- a disease that claims more than 400,000 lives around the world each year.
Related topics: Cancer, Oncology, Medical Research
(MedPage Today) -- Improvement over chemo seen in second-line for PD-L1 expressing tumors
Related topics: Cancer, Oncology, Chemotherapy
WEDNESDAY, Jan. 9, 2019 -- Hybrid minimally invasive esophagectomy results in lower incidence of intraoperative and postoperative major complications compared with open esophagectomy for esophageal cancer, according to a study published in the...
Related topics: Cancer, Oncology, Medical Research